| Biotechnology Industry | Healthcare Sector | Dr. Hao Hong Ph.D. CEO | XSHE Exchange | CNE100002BZ6 ISIN |
| CN Country | 9,595 Employees | 26 Jun 2026 Last Dividend | 14 Jun 2017 Last Split | - IPO Date |
Asymchem Laboratories (Tianjin) Co., Ltd. is a prominent player in the contract development and manufacturing sector, providing comprehensive services that foster the innovation and commercial application of pharmaceutical technology not just in Mainland China, but on an international scale. Established in 1999 and headquartered in Tianjin, China, Asymchem has solidified its reputation by offering a wide range of solutions to pharmaceutical and biotech companies. These solutions encompass various stages of drug development and production, from early clinical to commercial stages. Asymchem's commitment to excellence is evident in their provision of research and development, as well as cGMP (current Good Manufacturing Practices) production services for advanced intermediates, active pharmaceutical ingredients (APIs), and formulations. Furthermore, the company extends its services to include clinical research, highlighting its role as an integral partner in the pharmaceutical industry's R&D and production spectrum.
Asymchem Laboratories offers a comprehensive suite of products and services designed to meet the multifaceted needs of the pharmaceutical and biotechnology sectors, including: